Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam.
College of Health Sciences, VinUniversity, Hanoi, Vietnam.
Stem Cell Res Ther. 2022 Jan 10;13(1):15. doi: 10.1186/s13287-021-02694-y.
Although umbilical cord blood (UCB) is identified as a source of mesenchymal stem cells (MSCs) with various advantages, the success in cell isolation is volatile. Therefore, it is necessary to optimize methods of cord blood-derived MSC (UCB-MSC) isolation and culture. In this study, we evaluated the efficiency of UCB-MSC isolation and expansion using different commercially available serum- and xeno-free media and investigated the capacity of autologous serum and plasma as a supplement to support cell proliferation. Additionally, we defined the presence of multilineage-differentiating stress-enduring (Muse) cells in the UCB-MSC population. Functions of UCB-MSC in in vitro angiogenesis processes and anti-cancer were also verified.
Mononuclear cells were isolated using density gradient separation and cultured in four commercial media kits, as well as four surface coating solutions. UCB-MSCs were characterized and tested on tube formation assay, and co-cultured with SK-MEL cells in a transwell system.
The results showed that only StemMACS™ MSC Expansion Media is more appropriate to isolate and culture UCB-MSCs. The cells exhibited a high cell proliferation rate, CFU forming capability, MSC surface marker expression, trilineage differentiate potential, and chromosome stability. In addition, the culture conditions with autologous serum coating and autologous plasma supplement enhanced cell growth and colony forming. This cell population contained Muse cells at rate of 0.3%. Moreover, UCB-MSCs could induce the tube formation of human umbilical vein endothelial cells and inhibit more than 50% of SK-MEL cell growth.
UCB-MSCs could be high-yield isolated and expanded under serum- and xeno-free conditions by using the StemMACS™ MSC Expansion Media kit. Autologous serum coating and plasma supplement enhanced cell proliferation. These UCB-MSCs had effected the tube formation process and an anti-cancer impact.
尽管脐带血(UCB)被鉴定为具有多种优势的间充质干细胞(MSCs)的来源,但细胞分离的成功率却不稳定。因此,有必要优化脐带血源性 MSC(UCB-MSC)分离和培养的方法。在这项研究中,我们评估了使用不同商品化的无血清和无动物源培养基分离和扩增 UCB-MSC 的效率,并研究了自体血清和血浆作为补充物以支持细胞增殖的能力。此外,我们还定义了 UCB-MSC 群体中存在多谱系分化应激耐受(Muse)细胞。还验证了 UCB-MSC 在体外血管生成过程和抗癌中的功能。
使用密度梯度分离法分离单核细胞,并在四种商业培养基试剂盒以及四种表面涂层溶液中进行培养。对 UCB-MSC 进行特征鉴定和测试,包括管形成测定和在 Transwell 系统中与 SK-MEL 细胞共培养。
结果表明,只有 StemMACS™ MSC 扩增培养基更适合分离和培养 UCB-MSCs。这些细胞表现出较高的细胞增殖率、CFU 形成能力、MSC 表面标志物表达、三系分化潜能和染色体稳定性。此外,使用自体血清涂层和自体血浆补充的培养条件可增强细胞生长和集落形成。该细胞群体中 Muse 细胞的比例为 0.3%。此外,UCB-MSCs 可诱导人脐静脉内皮细胞的管形成,并抑制 SK-MEL 细胞生长超过 50%。
通过使用 StemMACS™ MSC 扩增培养基试剂盒,可在无血清和无动物源条件下高效分离和扩增 UCB-MSCs。自体血清涂层和血浆补充可增强细胞增殖。这些 UCB-MSCs 对管形成过程和抗癌有影响。